Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies. | Int J Mol Sci | 2023 | 37298481 | PubTator, text mining | PubMed |
| Prospective Evaluation of Fetal Hemoglobin Expression in Maternal Erythrocytes: An Analysis of a Cohort of 345 Parturients. | Diagnostics (Basel) | 2023 | 37296725 | PubTator, text mining | PubMed |
| Generation of Red Blood Cells from Human Pluripotent Stem Cells-An Update. | Cells | 2023 | 37296674 | PubTator, text mining | PubMed |
| Biomaterial-based gene therapy. | MedComm (2020) | 2023 | 37284583 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals developmental deficiencies in both the placentation and the decidualization in women with late-onset preeclampsia. | Front Immunol | 2023 | 37283740 | PubTator, text mining | PubMed |
| Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response. | NPJ Vaccines | 2023 | 37280322 | PubTator, text mining | PubMed |
| Engineering of the endogenous HBD promoter increases HbA2. | Elife | 2023 | 37265399 | PubTator, text mining | PubMed |
| Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy. | Drug Des Devel Ther | 2023 | 37255740 | PubTator, text mining | PubMed |
| Efficacy of Hydroxyurea in Transfusion-Dependent Major β-Thalassemia Patients: A Meta-Analysis. | Cureus | 2023 | 37252463 | PubTator, text mining | PubMed |
| Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review. | Arch Microbiol | 2023 | 37249707 | PubTator, text mining | PubMed |
| Reducing the inherent auto-inhibitory interaction within the pegRNA enhances prime editing efficiency. | Nucleic Acids Res | 2023 | 37246708 | PubTator, text mining | PubMed |
| Molecular and Genetics-Based Systems for Tracing the Evolution and Exploring the Mechanisms of Human Norovirus Infections. | Int J Mol Sci | 2023 | 37240438 | PubTator, text mining | PubMed |
| Are Genetic Modifiers the Answer to Different Responses to Hydroxyurea Treatment?-A Pharmacogenetic Study in Sickle Cell Anemia Angolan Children. | Int J Mol Sci | 2023 | 37240136 | PubTator, text mining | PubMed |
| Multiplexed Gene Engineering Based on dCas9 and gRNA-tRNA Array Encoded on Single Transcript. | Int J Mol Sci | 2023 | 37239880 | PubTator, text mining | PubMed |
| Positive Regulation of Splicing of Cellular and Viral mRNA by Intragenic RNA Elements That Activate the Stress Kinase PKR, an Antiviral Mechanism. | Genes (Basel) | 2023 | 37239334 | PubTator, text mining | PubMed |
| Globin Associated Oxidative Stress. | Antioxidants (Basel) | 2023 | 37237943 | PubTator, text mining | PubMed |
| Dietary patterns, obesity markers and leukocyte telomere length among Brazilian civil servants: cross-sectional results from the Pro-Saude study. | Public Health Nutr | 2023 | 37231745 | PubTator, text mining | PubMed |
| Immortalized erythroid cells as a novel frontier for in vitro blood production: current approaches and potential clinical application. | Stem Cell Res Ther | 2023 | 37226267 | PubTator, text mining | PubMed |
| The association between dietary acrylamide intake and the risk of type 2 diabetes incidence in the Tehran lipid and glucose study. | Sci Rep | 2023 | 37217800 | PubTator, text mining | PubMed |
| Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies. | Mol Ther Nucleic Acids | 2023 | 37215154 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=18